Nctid:
NCT00002524
Payload:
{"hasResults"=>false, "derivedSection"=>{"miscInfoModule"=>{"versionHolder"=>"2024-12-20"}, "conditionBrowseModule"=>{"meshes"=>[{"id"=>"D008223", "term"=>"Lymphoma"}, {"id"=>"D016483", "term"=>"Lymphoma, AIDS-Related"}], "ancestors"=>[{"id"=>"D009370", "term"=>"Neoplasms by Histologic Type"}, {"id"=>"D009369", "term"=>"Neoplasms"}, {"id"=>"D008232", "term"=>"Lymphoproliferative Disorders"}, {"id"=>"D008206", "term"=>"Lymphatic Diseases"}, {"id"=>"D007160", "term"=>"Immunoproliferative Disorders"}, {"id"=>"D007154", "term"=>"Immune System Diseases"}, {"id"=>"D016393", "term"=>"Lymphoma, B-Cell"}, {"id"=>"D008228", "term"=>"Lymphoma, Non-Hodgkin"}], "browseLeaves"=>[{"id"=>"M11220", "name"=>"Lymphoma", "asFound"=>"Lymphoma", "relevance"=>"HIGH"}, {"id"=>"M18831", "name"=>"Lymphoma, Large B-Cell, Diffuse", "relevance"=>"LOW"}, {"id"=>"M11222", "name"=>"Lymphoma, Non-Hodgkin", "relevance"=>"LOW"}, {"id"=>"M18888", "name"=>"Lymphoma, AIDS-Related", "asFound"=>"AIDS-Related Lymphoma", "relevance"=>"HIGH"}, {"id"=>"M381", "name"=>"Plasmablastic Lymphoma", "relevance"=>"LOW"}, {"id"=>"M18830", "name"=>"Lymphoma, Large-Cell, Immunoblastic", "relevance"=>"LOW"}, {"id"=>"M12315", "name"=>"Neoplasms by Histologic Type", "relevance"=>"LOW"}, {"id"=>"M11225", "name"=>"Lymphoproliferative Disorders", "relevance"=>"LOW"}, {"id"=>"M11203", "name"=>"Lymphatic Diseases", "relevance"=>"LOW"}, {"id"=>"M10206", "name"=>"Immunoproliferative Disorders", "relevance"=>"LOW"}, {"id"=>"M10200", "name"=>"Immune System Diseases", "relevance"=>"LOW"}, {"id"=>"M18828", "name"=>"Lymphoma, B-Cell", "relevance"=>"LOW"}, {"id"=>"T3543", "name"=>"Lymphosarcoma", "asFound"=>"Lymphoma", "relevance"=>"HIGH"}, {"id"=>"T1866", "name"=>"Diffuse Large B-Cell Lymphoma", "relevance"=>"LOW"}, {"id"=>"T4686", "name"=>"Primary Central Nervous System Lymphoma", "relevance"=>"LOW"}, {"id"=>"T3538", "name"=>"Lymphoma AIDS Related", "asFound"=>"AIDS-Related Lymphoma", "relevance"=>"HIGH"}, {"id"=>"T4690", "name"=>"Primary Effusion Lymphoma", "asFound"=>"AIDS-Related Lymphoma", "relevance"=>"HIGH"}, {"id"=>"T4586", "name"=>"Plasmablastic Lymphoma", "relevance"=>"LOW"}, {"id"=>"T3539", "name"=>"Lymphoma, Large-cell, Immunoblastic", "relevance"=>"LOW"}, {"id"=>"T640", "name"=>"B-cell Lymphoma", "relevance"=>"LOW"}], "browseBranches"=>[{"name"=>"Neoplasms", "abbrev"=>"BC04"}, {"name"=>"Blood and Lymph Conditions", "abbrev"=>"BC15"}, {"name"=>"Immune System Diseases", "abbrev"=>"BC20"}, {"name"=>"All Conditions", "abbrev"=>"All"}, {"name"=>"Rare Diseases", "abbrev"=>"Rare"}]}, "interventionBrowseModule"=>{"meshes"=>[{"id"=>"D002955", "term"=>"Leucovorin"}, {"id"=>"D003561", "term"=>"Cytarabine"}, {"id"=>"D015215", "term"=>"Zidovudine"}, {"id"=>"D014295", "term"=>"Trimethoprim"}, {"id"=>"D013420", "term"=>"Sulfamethoxazole"}, {"id"=>"D015662", "term"=>"Trimethoprim, Sulfamethoxazole Drug Combination"}, {"id"=>"D010419", "term"=>"Pentamidine"}, {"id"=>"D011241", "term"=>"Prednisone"}, {"id"=>"D008775", "term"=>"Methylprednisolone"}, {"id"=>"D000077555", "term"=>"Methylprednisolone Acetate"}, {"id"=>"D008776", "term"=>"Methylprednisolone Hemisuccinate"}, {"id"=>"D011239", "term"=>"Prednisolone"}, {"id"=>"C009935", "term"=>"Prednisolone acetate"}, {"id"=>"D003520", "term"=>"Cyclophosphamide"}, {"id"=>"D007069", "term"=>"Ifosfamide"}, {"id"=>"D004317", "term"=>"Doxorubicin"}, {"id"=>"C506643", "term"=>"Liposomal doxorubicin"}, {"id"=>"D005472", "term"=>"Fluorouracil"}, {"id"=>"D008727", "term"=>"Methotrexate"}, {"id"=>"D005047", "term"=>"Etoposide"}, {"id"=>"D014750", "term"=>"Vincristine"}, {"id"=>"D001761", "term"=>"Bleomycin"}, {"id"=>"C021322", "term"=>"Prednisolone hemisuccinate"}, {"id"=>"C009022", "term"=>"Prednisolone phosphate"}, {"id"=>"D058766", "term"=>"Levoleucovorin"}], "ancestors"=>[{"id"=>"D007166", "term"=>"Immunosuppressive Agents"}, {"id"=>"D007155", "term"=>"Immunologic Factors"}, {"id"=>"D045505", "term"=>"Physiological Effects of Drugs"}, {"id"=>"D018501", "term"=>"Antirheumatic Agents"}, {"id"=>"D018906", "term"=>"Antineoplastic Agents, Alkylating"}, {"id"=>"D000477", "term"=>"Alkylating Agents"}, {"id"=>"D045504", "term"=>"Molecular Mechanisms of Pharmacological Action"}, {"id"=>"D000970", "term"=>"Antineoplastic Agents"}, {"id"=>"D019653", "term"=>"Myeloablative Agonists"}, {"id"=>"D000903", "term"=>"Antibiotics, Antineoplastic"}, {"id"=>"D059005", "term"=>"Topoisomerase II Inhibitors"}, {"id"=>"D059003", "term"=>"Topoisomerase Inhibitors"}, {"id"=>"D004791", "term"=>"Enzyme Inhibitors"}, {"id"=>"D000893", "term"=>"Anti-Inflammatory Agents"}, {"id"=>"D005938", "term"=>"Glucocorticoids"}, {"id"=>"D006728", "term"=>"Hormones"}, {"id"=>"D006730", "term"=>"Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id"=>"D018931", "term"=>"Antineoplastic Agents, Hormonal"}, {"id"=>"D000963", "term"=>"Antimetabolites"}, {"id"=>"D000964", "term"=>"Antimetabolites, Antineoplastic"}, {"id"=>"D000020", "term"=>"Abortifacient Agents, Nonsteroidal"}, {"id"=>"D000019", "term"=>"Abortifacient Agents"}, {"id"=>"D012102", "term"=>"Reproductive Control Agents"}, {"id"=>"D003879", "term"=>"Dermatologic Agents"}, {"id"=>"D005493", "term"=>"Folic Acid Antagonists"}, {"id"=>"D019384", "term"=>"Nucleic Acid Synthesis Inhibitors"}, {"id"=>"D000972", "term"=>"Antineoplastic Agents, Phytogenic"}, {"id"=>"D000998", "term"=>"Antiviral Agents"}, {"id"=>"D000890", "term"=>"Anti-Infective Agents"}, {"id"=>"D000931", "term"=>"Antidotes"}, {"id"=>"D020011", "term"=>"Protective Agents"}, {"id"=>"D014803", "term"=>"Vitamin B Complex"}, {"id"=>"D014815", "term"=>"Vitamins"}, {"id"=>"D018977", "term"=>"Micronutrients"}, {"id"=>"D050257", "term"=>"Tubulin Modulators"}, {"id"=>"D050256", "term"=>"Antimitotic Agents"}, {"id"=>"D050258", "term"=>"Mitosis Modulators"}, {"id"=>"D000932", "term"=>"Antiemetics"}, {"id"=>"D001337", "term"=>"Autonomic Agents"}, {"id"=>"D018373", "term"=>"Peripheral Nervous System Agents"}, {"id"=>"D005765", "term"=>"Gastrointestinal Agents"}, {"id"=>"D018696", "term"=>"Neuroprotective Agents"}, {"id"=>"D018894", "term"=>"Reverse Transcriptase Inhibitors"}, {"id"=>"D019380", "term"=>"Anti-HIV Agents"}, {"id"=>"D044966", "term"=>"Anti-Retroviral Agents"}, {"id"=>"D000892", "term"=>"Anti-Infective Agents, Urinary"}, {"id"=>"D000962", "term"=>"Antimalarials"}, {"id"=>"D000981", "term"=>"Antiprotozoal Agents"}, {"id"=>"D000977", "term"=>"Antiparasitic Agents"}, {"id"=>"D018726", "term"=>"Anti-Dyskinesia Agents"}, {"id"=>"D065687", "term"=>"Cytochrome P-450 CYP2C8 Inhibitors"}, {"id"=>"D065607", "term"=>"Cytochrome P-450 Enzyme Inhibitors"}, {"id"=>"D000900", "term"=>"Anti-Bacterial Agents"}, {"id"=>"D000935", "term"=>"Antifungal Agents"}, {"id"=>"D014344", "term"=>"Trypanocidal Agents"}], "browseLeaves"=>[{"id"=>"M8600", "name"=>"Fluorouracil", "asFound"=>"Min", "relevance"=>"HIGH"}, {"id"=>"M7492", "name"=>"Doxorubicin", "asFound"=>"Virtual", "relevance"=>"HIGH"}, {"id"=>"M227339", "name"=>"Liposomal doxorubicin", "asFound"=>"Virtual", "relevance"=>"HIGH"}, {"id"=>"M6766", "name"=>"Cytarabine", "asFound"=>"6 months", "relevance"=>"HIGH"}, {"id"=>"M6727", "name"=>"Cyclophosphamide", "asFound"=>"Was", "relevance"=>"HIGH"}, {"id"=>"M14121", "name"=>"Prednisone", "asFound"=>"Technique", "relevance"=>"HIGH"}, {"id"=>"M17495", "name"=>"Vincristine", "asFound"=>"Ratio", "relevance"=>"HIGH"}, {"id"=>"M6191", "name"=>"Leucovorin", "asFound"=>"May", "relevance"=>"HIGH"}, {"id"=>"M8191", "name"=>"Etoposide", "asFound"=>"Different", "relevance"=>"HIGH"}, {"id"=>"M11703", "name"=>"Methotrexate", "asFound"=>"Brain", "relevance"=>"HIGH"}, {"id"=>"M341643", "name"=>"Etoposide phosphate", "relevance"=>"LOW"}, {"id"=>"M1945", "name"=>"Lenograstim", "relevance"=>"LOW"}, {"id"=>"M17047", "name"=>"Trimethoprim", "asFound"=>"Decision aid", "relevance"=>"HIGH"}, {"id"=>"M16206", "name"=>"Sulfamethoxazole", "asFound"=>"Twice per day", "relevance"=>"HIGH"}, {"id"=>"M11749", "name"=>"Methylprednisolone", "asFound"=>"Specimen", "relevance"=>"HIGH"}, {"id"=>"M1833", "name"=>"Methylprednisolone Acetate", "asFound"=>"Specimen", "relevance"=>"HIGH"}, {"id"=>"M11750", "name"=>"Methylprednisolone Hemisuccinate", "asFound"=>"Specimen", "relevance"=>"HIGH"}, {"id"=>"M14120", "name"=>"Prednisolone", "asFound"=>"Specimen", "relevance"=>"HIGH"}, {"id"=>"M229449", "name"=>"Prednisolone acetate", "asFound"=>"Specimen", "relevance"=>"HIGH"}, {"id"=>"M211887", "name"=>"Prednisolone hemisuccinate", "asFound"=>"Specimen", "relevance"=>"HIGH"}, {"id"=>"M248881", "name"=>"Prednisolone phosphate", "asFound"=>"Specimen", "relevance"=>"HIGH"}, {"id"=>"M5381", "name"=>"Calcium", "relevance"=>"LOW"}, {"id"=>"M6182", "name"=>"Cisplatin", "relevance"=>"LOW"}, {"id"=>"M5042", "name"=>"Bleomycin", "asFound"=>"Sedentary behavior", "relevance"=>"HIGH"}, {"id"=>"M18253", "name"=>"Trimethoprim, Sulfamethoxazole Drug Combination", "asFound"=>"Electronic medical record", "relevance"=>"HIGH"}, {"id"=>"M5398", "name"=>"Calcium, Dietary", "relevance"=>"LOW"}, {"id"=>"M29233", "name"=>"Levoleucovorin", "asFound"=>"Started", "relevance"=>"HIGH"}, {"id"=>"M10117", "name"=>"Ifosfamide", "asFound"=>"Steroid", "relevance"=>"HIGH"}, {"id"=>"M230811", "name"=>"Isophosphamide mustard", "relevance"=>"LOW"}, {"id"=>"M13330", "name"=>"Pentamidine", "asFound"=>"Lemon", "relevance"=>"HIGH"}, {"id"=>"M17920", "name"=>"Zidovudine", "asFound"=>"Corticosteroid", "relevance"=>"HIGH"}, {"id"=>"M10212", "name"=>"Immunosuppressive Agents", "relevance"=>"LOW"}, {"id"=>"M10201", "name"=>"Immunologic Factors", "relevance"=>"LOW"}, {"id"=>"M20604", "name"=>"Antirheumatic Agents", "relevance"=>"LOW"}, {"id"=>"M20942", "name"=>"Antineoplastic Agents, Alkylating", "relevance"=>"LOW"}, {"id"=>"M3820", "name"=>"Alkylating Agents", "relevance"=>"LOW"}, {"id"=>"M4222", "name"=>"Anti-Bacterial Agents", "relevance"=>"LOW"}, {"id"=>"M4224", "name"=>"Antibiotics, Antitubercular", "relevance"=>"LOW"}, {"id"=>"M7951", "name"=>"Enzyme Inhibitors", "relevance"=>"LOW"}, {"id"=>"M4217", "name"=>"Anti-Inflammatory Agents", "relevance"=>"LOW"}, {"id"=>"M9047", "name"=>"Glucocorticoids", "relevance"=>"LOW"}, {"id"=>"M9789", "name"=>"Hormones", "relevance"=>"LOW"}, {"id"=>"M9788", "name"=>"Hormone Antagonists", "relevance"=>"LOW"}, {"id"=>"M20966", "name"=>"Antineoplastic Agents, Hormonal", "relevance"=>"LOW"}, {"id"=>"M4281", "name"=>"Antimetabolites", "relevance"=>"LOW"}, {"id"=>"M7074", "name"=>"Dermatologic Agents", "relevance"=>"LOW"}, {"id"=>"M8618", "name"=>"Folic Acid", "relevance"=>"LOW"}, {"id"=>"M17546", "name"=>"Vitamin B Complex", "relevance"=>"LOW"}, {"id"=>"M8619", "name"=>"Folic Acid Antagonists", "relevance"=>"LOW"}, {"id"=>"M4314", "name"=>"Antiviral Agents", "relevance"=>"LOW"}, {"id"=>"M4214", "name"=>"Anti-Infective Agents", "relevance"=>"LOW"}, {"id"=>"M4250", "name"=>"Antidotes", "relevance"=>"LOW"}, {"id"=>"M21869", "name"=>"Protective Agents", "relevance"=>"LOW"}, {"id"=>"M17558", "name"=>"Vitamins", "relevance"=>"LOW"}, {"id"=>"M21009", "name"=>"Micronutrients", "relevance"=>"LOW"}, {"id"=>"M16885", "name"=>"Trace Elements", "relevance"=>"LOW"}, {"id"=>"M26197", "name"=>"Tubulin Modulators", "relevance"=>"LOW"}, {"id"=>"M26196", "name"=>"Antimitotic Agents", "relevance"=>"LOW"}, {"id"=>"M4251", "name"=>"Antiemetics", "relevance"=>"LOW"}, {"id"=>"M8881", "name"=>"Gastrointestinal Agents", "relevance"=>"LOW"}, {"id"=>"M20773", "name"=>"Neuroprotective Agents", "relevance"=>"LOW"}, {"id"=>"M20935", "name"=>"Reverse Transcriptase Inhibitors", "relevance"=>"LOW"}, {"id"=>"M21350", "name"=>"Anti-HIV Agents", "relevance"=>"LOW"}, {"id"=>"M25428", "name"=>"Anti-Retroviral Agents", "relevance"=>"LOW"}, {"id"=>"M4280", "name"=>"Antimalarials", "relevance"=>"LOW"}, {"id"=>"M4298", "name"=>"Antiprotozoal Agents", "relevance"=>"LOW"}, {"id"=>"M4294", "name"=>"Antiparasitic Agents", "relevance"=>"LOW"}, {"id"=>"M30537", "name"=>"Cytochrome P-450 Enzyme Inhibitors", "relevance"=>"LOW"}, {"id"=>"M4254", "name"=>"Antifungal Agents", "relevance"=>"LOW"}, {"id"=>"M6252", "name"=>"Clotrimazole", "relevance"=>"LOW"}, {"id"=>"M11796", "name"=>"Miconazole", "relevance"=>"LOW"}, {"id"=>"T447", "name"=>"Folinic Acid", "asFound"=>"Started", "relevance"=>"HIGH"}, {"id"=>"T446", "name"=>"Folic Acid", "relevance"=>"LOW"}, {"id"=>"T448", "name"=>"Folate", "relevance"=>"LOW"}, {"id"=>"T475", "name"=>"Vitamin B9", "relevance"=>"LOW"}], "browseBranches"=>[{"name"=>"Antineoplastic Agents", "abbrev"=>"ANeo"}, {"name"=>"All Drugs and Chemicals", "abbrev"=>"All"}, {"name"=>"Anti-Infective Agents", "abbrev"=>"Infe"}, {"name"=>"Antirheumatic Agents", "abbrev"=>"ARhu"}, {"name"=>"Anti-Inflammatory Agents", "abbrev"=>"Infl"}, {"name"=>"Micronutrients", "abbrev"=>"Micro"}, {"name"=>"Dermatologic Agents", "abbrev"=>"Derm"}, {"name"=>"Reproductive Control Agents", "abbrev"=>"Repr"}, {"name"=>"Anti-Dyskinesia Agents", "abbrev"=>"AnDyAg"}, {"name"=>"Antiemetics", "abbrev"=>"AnEm"}, {"name"=>"Neuroprotective Agents", "abbrev"=>"NeuroAg"}, {"name"=>"Gastrointestinal Agents", "abbrev"=>"Gast"}, {"name"=>"Bone Density Conservation Agents", "abbrev"=>"BDCA"}, {"name"=>"Hematinics", "abbrev"=>"Hemat"}, {"name"=>"Vitamins", "abbrev"=>"Vi"}]}}, "protocolSection"=>{"designModule"=>{"phases"=>["PHASE2"], "studyType"=>"INTERVENTIONAL", "designInfo"=>{"allocation"=>"NON_RANDOMIZED", "maskingInfo"=>{"masking"=>"NONE"}, "primaryPurpose"=>"TREATMENT", "interventionModel"=>"SINGLE_GROUP"}, "enrollmentInfo"=>{"type"=>"ACTUAL", "count"=>46}}, "statusModule"=>{"overallStatus"=>"COMPLETED", "startDateStruct"=>{"date"=>"1993-06"}, "expandedAccessInfo"=>{"hasExpandedAccess"=>false}, "statusVerifiedDate"=>"2012-07", "completionDateStruct"=>{"date"=>"2005-10", "type"=>"ACTUAL"}, "lastUpdateSubmitDate"=>"2012-07-27", "studyFirstSubmitDate"=>"1999-11-01", "studyFirstSubmitQcDate"=>"2004-10-04", "lastUpdatePostDateStruct"=>{"date"=>"2012-07-30", "type"=>"ESTIMATED"}, "studyFirstPostDateStruct"=>{"date"=>"2004-10-05", "type"=>"ESTIMATED"}, "primaryCompletionDateStruct"=>{"date"=>"2005-10", "type"=>"ACTUAL"}}, "outcomesModule"=>{"primaryOutcomes"=>[{"measure"=>"Number of Patients with Clinical Response", "timeFrame"=>"3 Years", "description"=>"Clinical Responses categorized by: Complete Response (CR), Partial Response (PR), Minor Response, Stable Disease or Progressive Disease"}]}, "oversightModule"=>{"oversightHasDmc"=>false}, "conditionsModule"=>{"keywords"=>["AIDS-related peripheral/systemic lymphoma", "AIDS-related primary CNS lymphoma", "AIDS-related diffuse large cell lymphoma", "AIDS-related immunoblastic large cell lymphoma", "AIDS-related small noncleaved cell lymphoma", "AIDS-related diffuse mixed cell lymphoma", "AIDS-related diffuse small cleaved cell lymphoma"], "conditions"=>["Lymphoma"]}, "referencesModule"=>{"seeAlsoLinks"=>[{"url"=>"http://www.mdanderson.org", "label"=>"UT MD Anderson Cancer Center Website"}]}, "descriptionModule"=>{"briefSummary"=>"RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.\n\nPURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.", "detailedDescription"=>"OBJECTIVES: I. Develop an effective chemotherapy regimen with mild immunosuppressive and myelosuppressive properties to treat patients with AIDS-related lymphoma (ARL) who have severe T4 lymphopenia. II. Estimate the CR rate, lymphoma-free survival, and overall survival of non-T4 lymphopenic patients and patients who present with nonbulky Ann Arbor stage I ARL treated with standard regimens of known effectiveness. III. Evaluate the effects on long-term outlook of concurrent antiretroviral therapy, prophylactic antibiosis with trimethoprim/sulfamethoxazole or aerosolized pentamidine, and prn use of granulocyte colony-stimulating factor for severe myelosuppression.\n\nOUTLINE: Patients are assigned to Regimens A, B, and C according to histology and extent of disease and the degree of immunosuppression as follows: Regimen A: Patients with Ann Arbor stage I intermediate grade or immunoblastic lymphoma with measurable nonbulky disease (less than 7 cm), low LDH (less than 686), and no prior opportunistic infection irrespective of T4 count; also those with nonmeasurable stage I extranodal primaries (infiltration of less than 2/3 of an organ site, e.g., stomach, rectum, esophagus, sinus cavity) irrespective of T4 count. Regimen B: All patients (except primary brain lymphoma patients) not assigned to Regimen A who have T4 counts of at least 200 and no history of opportunistic infection; includes all stages of small noncleaved cell lymphoma and bulky stage I and stages II-IV intermediate grade and immunoblastic lymphoma. Regimen C: Patients not assigned to Regimen A or B, i.e., those with T4 counts less than 200 and/or a history of opportunistic infection and those with primary brain lymphoma. The following acronyms are used: ARA-C Cytarabine, NSC-63878 BLEO Bleomycin, NSC-125066 CDDP Cisplatin, NSC-119875 CF Leucovorin calcium, NSC-3590 CTX Cyclophosphamide, NSC-26271 DOX Doxorubicin, NSC-123127 5-FU Fluorouracil, NSC-19893 G-CSF Granulocyte Colony-Stimulating Factor (Amgen), NSC-614629 IFF Ifosfamide, NSC-109723 MePRDL Methylprednisolone succinate Mesna Mercaptoethane sulfonate, NSC-113891 MTX Methotrexate, NSC-740 PRED Prednisone, NSC-10023 VCR Vincristine, NSC-67574 VP-16 Etoposide, NSC-141540 ZDV Zidovudine, NSC-602670 Regimen A: 5-Drug Combination Chemotherapy followed by Radiotherapy. CHOP-BLEO: CTX; DOX; VCR; PRED; BLEO; followed by involved-field irradiation with megavoltage equipment. Regimen B: 4-Drug Combination Chemotherapy alternating with 3-Drug Combination Chemotherapy followed, as indicated, by Radiotherapy. ASHAP: DOX; MePRDL; ARA-C; CDDP; alternating with IMVP-16: IFF/Mesna; MTX/CF; VP-16; followed, in selected patients with initially bulky localized disease, by involved-field irradiation with megavoltage equipment. Regimen C: 2-Drug Combination Chemotherapy with Drug Modulation followed, as indicated, by Radiotherapy. FLEP: 5-FU/CF/CDDP; followed, in selected patients with initially bulky localized disease, by involved-field irradiation with megavoltage equipment. Prior to starting chemotherapy, patients with primary brain lymphoma receive a course of cranial irradiation using accelerator beams with photon energies of 6-15 MV.\n\nPROJECTED ACCRUAL: Up to 92 patients (10 for Regimen A, 28 for Regimen B, 54 for Regimen C) will be entered over 3 years. If there are no CRs among the first 6 patients on Regimens A and B or the first 19 patients on Regimen C, accrual to that regimen will cease. If more than 4 infectious deaths occur among the first 10 patients or if the rate of disease progression exceeds 20% on any regimen, further accrual to that regimen will cease."}, "eligibilityModule"=>{"sex"=>"ALL", "stdAges"=>["CHILD", "ADULT", "OLDER_ADULT"], "minimumAge"=>"15 years", "healthyVolunteers"=>false, "eligibilityCriteria"=>"DISEASE CHARACTERISTICS: Previously untreated, HIV-related intermediate- and high-grade lymphoma with no previous diagnosis of Kaposi's sarcoma Pathology reviewed at M.D. Anderson Cancer Center\n\nPATIENT CHARACTERISTICS: Age: Over 15 Performance status: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: For patients with T4 less than 200 and those with primary brain lymphoma: Creatinine no greater than 2.0 mg/dL (unless entry approved by principal investigator) Other: Serious intercurrent illness must be discussed with the principal investigator Infectious disease consultation required for complex infections Medications for other conditions allowed provided no adverse interaction with protocol therapy occurs No previously diagnosed Kaposi's sarcoma or other malignancy\n\nPRIOR CONCURRENT THERAPY: No prior therapy for lymphoma No concurrent chemotherapy"}, "identificationModule"=>{"nctId"=>"NCT00002524", "briefTitle"=>"Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma", "organization"=>{"class"=>"OTHER", "fullName"=>"M.D. Anderson Cancer Center"}, "officialTitle"=>"Pilot Study in AIDS-Related Lymphomas", "orgStudyIdInfo"=>{"id"=>"DM93-058"}, "secondaryIdInfos"=>[{"id"=>"P30CA016672", "link"=>"https://reporter.nih.gov/quickSearch/P30CA016672", "type"=>"NIH"}, {"id"=>"MDA-DM-93058", "type"=>"OTHER", "domain"=>"UT MD Anderson Cancer Center"}, {"id"=>"NCI-T93-0088D"}, {"id"=>"CDR0000078316", "type"=>"REGISTRY", "domain"=>"NCI PDQ"}]}, "armsInterventionsModule"=>{"armGroups"=>[{"type"=>"EXPERIMENTAL", "label"=>"Regimen A", "description"=>"Regimen A: 5-Drug Combination Chemotherapy followed by Radiotherapy.", "interventionNames"=>["Biological: Bleomycin Sulfate", "Drug: Cyclophosphamide", "Drug: Doxorubicin Hydrochloride (DOX)", "Drug: Pentamidine", "Drug: Prednisone", "Drug: Trimethoprim-Sulfamethoxazole", "Drug: Vincristine Sulfate", "Drug: Zidovudine (AZT)", "Radiation: Radiation Therapy"]}, {"type"=>"EXPERIMENTAL", "label"=>"Regimen B", "description"=>"Regimen B: 4-Drug Combination Chemotherapy alternating with 3-Drug Combination Chemotherapy followed, as indicated, by Radiotherapy", "interventionNames"=>["Biological: Filgrastim", "Drug: Cytarabine", "Drug: Doxorubicin Hydrochloride (DOX)", "Drug: Etoposide", "Drug: Ifosfamide", "Drug: Methotrexate", "Drug: Methylprednisolone", "Drug: Pentamidine", "Drug: Trimethoprim-Sulfamethoxazole", "Drug: Zidovudine (AZT)", "Radiation: Radiation Therapy"]}, {"type"=>"EXPERIMENTAL", "label"=>"Regimen C", "description"=>"Regimen C: 2-Drug Combination Chemotherapy with Drug Modulation followed, as indicated, by Radiotherapy.", "interventionNames"=>["Biological: Filgrastim", "Drug: Cisplatin", "Drug: Fluorouracil", "Drug: Leucovorin calcium", "Drug: Pentamidine", "Drug: Trimethoprim-Sulfamethoxazole", "Drug: Zidovudine (AZT)", "Radiation: Radiation Therapy"]}], "interventions"=>[{"name"=>"Bleomycin Sulfate", "type"=>"BIOLOGICAL", "otherNames"=>["Blenoxane", "BLM"], "armGroupLabels"=>["Regimen A"]}, {"name"=>"Filgrastim", "type"=>"BIOLOGICAL", "otherNames"=>["G-CSF", "Neupogen"], "armGroupLabels"=>["Regimen B", "Regimen C"]}, {"name"=>"Cisplatin", "type"=>"DRUG", "otherNames"=>["Platinol", "Plationol-AQ", "CDDP"], "armGroupLabels"=>["Regimen C"]}, {"name"=>"Cyclophosphamide", "type"=>"DRUG", "otherNames"=>["Cytoxan", "Neosar"], "armGroupLabels"=>["Regimen A"]}, {"name"=>"Cytarabine", "type"=>"DRUG", "otherNames"=>["Ara-C", "Cytosar", "DepoCyt", "Cytarabine arabinosine hydrochloride"], "armGroupLabels"=>["Regimen B"]}, {"name"=>"Doxorubicin Hydrochloride (DOX)", "type"=>"DRUG", "otherNames"=>["Adriamycin PFS", "Adriamycin RDF"], "armGroupLabels"=>["Regimen A", "Regimen B"]}, {"name"=>"Etoposide", "type"=>"DRUG", "otherNames"=>["VePesid"], "armGroupLabels"=>["Regimen B"]}, {"name"=>"Fluorouracil", "type"=>"DRUG", "otherNames"=>["5-FU", "Adrucil", "Efudex", "5-Fluorouracil"], "armGroupLabels"=>["Regimen C"]}, {"name"=>"Ifosfamide", "type"=>"DRUG", "otherNames"=>["Ifex"], "armGroupLabels"=>["Regimen B"]}, {"name"=>"Leucovorin calcium", "type"=>"DRUG", "otherNames"=>["Citrovorum", "Wellcovorin"], "armGroupLabels"=>["Regimen C"]}, {"name"=>"Methotrexate", "type"=>"DRUG", "armGroupLabels"=>["Regimen B"]}, {"name"=>"Methylprednisolone", "type"=>"DRUG", "otherNames"=>["Depo-Medrol", "Medrol", "Solu-Medrol"], "armGroupLabels"=>["Regimen B"]}, {"name"=>"Pentamidine", "type"=>"DRUG", "otherNames"=>["Pentam-300"], "armGroupLabels"=>["Regimen A", "Regimen B", "Regimen C"]}, {"name"=>"Prednisone", "type"=>"DRUG", "armGroupLabels"=>["Regimen A"]}, {"name"=>"Trimethoprim-Sulfamethoxazole", "type"=>"DRUG", "otherNames"=>["SMX", "Bactrim", "Cotrim", "Septra", "Sulfamethoprim", "Sulfatrim", "Sulfoxaprim", "Trisulfam", "Uroplus", "Co-trimoxazole", "SMX-TMP"], "armGroupLabels"=>["Regimen A", "Regimen B", "Regimen C"]}, {"name"=>"Vincristine Sulfate", "type"=>"DRUG", "armGroupLabels"=>["Regimen A"]}, {"name"=>"Zidovudine (AZT)", "type"=>"DRUG", "otherNames"=>["Retrovir"], "armGroupLabels"=>["Regimen A", "Regimen B", "Regimen C"]}, {"name"=>"Radiation Therapy", "type"=>"RADIATION", "otherNames"=>["RT", "Radiotherapy"], "armGroupLabels"=>["Regimen A", "Regimen B", "Regimen C"]}]}, "contactsLocationsModule"=>{"locations"=>[{"zip"=>"32806", "city"=>"Orlando", "state"=>"Florida", "country"=>"United States", "facility"=>"MD Anderson Cancer Center Orlando", "geoPoint"=>{"lat"=>28.53834, "lon"=>-81.37924}}, {"zip"=>"77030", "city"=>"Houston", "state"=>"Texas", "country"=>"United States", "facility"=>"University of Texas - MD Anderson Cancer Center", "geoPoint"=>{"lat"=>29.76328, "lon"=>-95.36327}}], "overallOfficials"=>[{"name"=>"Peter W. McLaughlin, MD", "role"=>"STUDY_CHAIR", "affiliation"=>"M.D. Anderson Cancer Center"}]}, "sponsorCollaboratorsModule"=>{"leadSponsor"=>{"name"=>"M.D. Anderson Cancer Center", "class"=>"OTHER"}, "collaborators"=>[{"name"=>"National Cancer Institute (NCI)", "class"=>"NIH"}], "responsibleParty"=>{"type"=>"SPONSOR"}}}}
